CONMED Corporation to Present at the 26th Annual Piper Jaffray Healthcare Conference
(firmenpresse) - UTICA, NY -- (Marketwired) -- 11/20/14 -- (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery, announced today that the Company will participate in the 26th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014 at 2:30 PM Eastern Time. The event will be held in New York City at the New York Palace Hotel.
Mr. Robert D. Shallish, Jr., Executive Vice-President and Chief Financial Officer of CONMED, will discuss the Company''s business. The live webcast of CONMED''s presentation will be available at in the Investors section of the website and will be available for replay through December 12, 2014.
CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures. Headquartered in Utica, New York, the Company''s 3,600 employees distribute its products worldwide with a direct selling presence in 16 countries outside the United States. International sales constitute approximately 50% of the Company''s revenues.
Certain statements made in the presentation may constitute forward-looking statements. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company''s performance on a going-forward basis. They will be based upon management''s expectations and involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements therein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management''s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to: (i) the failure of any one or more of management''s assumptions to prove to be correct; (ii) the risks relating to forward-looking statements discussed in the Company''s filings with the Securities and Exchange Commission, including the Company''s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and Quarterly Reports on Form 10-Q; (iii) cyclical purchasing patterns from customers, end-users and dealers; (iv) timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the possibility that any new acquisition (and its integration) or other transaction may require the Company to reconsider its financial assumptions and goals/targets; (vii) increasing costs for raw material, transportation, or litigation; (viii) the risk of a lack of allograft tissues due to reduced donations of such tissues or due to tissues not meeting the appropriate high standards for screening and/or processing of such tissues; and/or (ix) the Company''s ability to devise and execute strategies to respond to market conditions.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.11.2014 - 15:15 Uhr
Sprache: Deutsch
News-ID 1320294
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
UTICA, NY
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 184 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CONMED Corporation to Present at the 26th Annual Piper Jaffray Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
CONMED Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
